The heterogeneity of patients with different underlying biologies (e.g., LRRK2 mutations, GBA variants, or idiopathic forms) in the same cohorts is now recognized as an important driver for the failure of disease-modifying clinical trials to date [2, 9, 10]
Combined with oxidative stress biomarker assessment, this information may help determine whether glutathione is a rational choice for your skin health goals
The difference between a good outcome and a poor one almost always comes down to proper oversight
Therefore, therapeutic efforts are better directed toward neuronal and glial targets, which more directly govern disease onset and progression
In this article, we'll explore the vitamins that may interfere with inositol's effectiveness and how certain combinations could impact your overall well-being
T., & Kloner, R